Frequently Asked Questions
For main company contact names and addresses and other details read our Corporate Directory. For answers to questions about shares, stock exchange, buying and selling shares and more, consult the Frequently Asked Questions below.
Which stock exchange(s) is Benitec listed on?
Benitec Biopharma is listed on the:
- ASX (Australian Securities Exchange) with the ticker BLT
- US NASDAQ Capital Market with the ticker BNTC.
What is Benitec’s fiscal year?
Benitec’s fiscal year runs from July 1 to June 30.
Who are the auditors for Benitec Biopharma?
Benitec’s auditors are Grant Thornton Audit Pty Ltd.
How can I obtain a copy of Benitec’s Annual Report?
A copy of the annual report can be downloaded from the Reports section in the Investor Centre. The report is available for download in Adobe Acrobat format.
Alternatively, printed copies of the Annual Report can be mailed out. If you would like a printed copy of the Annual report, please contact us.
Who maintains Benitecs Share Register?
Benitec’s share register is maintained by Computershare. You may contact Computershare Investor Services on 1300 850 505 (from Australia) or +61 3 9415 4000 (from overseas).
How do I buy and sell ordinary shares in Benitec?
All shares listed on the ASX can be bought or sold through a broker. A stockbroker acts as your agent to buy or sell shares on your behalf, for which a fee is charged. A broker can also provide a range of services including the provision of advice on which shares to buy or sell. Most stockbroking firms require you to provide funds prior to accepting your first order to buy shares.
For more information, please refer to the links below:
Does Benitec pay dividends?
Benitec has not paid any dividends in respect of the current or previous financial year. The Company is not expecting to pay a dividend for a number of years until Benitec and its projects reach commercialisation.
Is there a minimum number of shares I need to purchase to become a shareholder?
The minimum amount of shares under ASX listing rules is $500 worth of shares. Benitec suggests that individuals discuss the purchase of any shares with a financial advisor or broker to determine what the optimal number to buy would be considering budget and personal factors.
How do I contact Investor Relations?
For investor relations, refer details on Benitec’s Contact Us.
What does Issuer Sponsored mean?
An Issuer Sponsored holding is maintained by Computershare, which maintains all details relating to the holding. All Benitec shares quoted on the Australian Securities Exchange (ASX) are required to be uncertificated.
Issuer sponsorship is the means by which shareholders must hold their shares in uncertificated form if they are not sponsored by a participant in CHESS, such as a share broker.
Your Issuer Sponsored holdings can be identified by an ‘I’ at the start of your Shareholder Reference Number (SRN) which is printed on your holding statement. When your shares are Issuer Sponsored, you are free to trade them through any broker. You give your nominated broker permission to access your holding when you buy or sell shares.
What does Broker Sponsored mean?
If your shares are Broker Sponsored, you will have a Holder Identification Number (HIN) allocated to you that is prefixed with an ‘X’. All on-market transactions in Benitec securities are advised electronically to the Benitec Share Registry through CHESS (Clearing House Electronic Subregister System).
When your shares are Broker Sponsored, you are only able to sell them through that broker. If you wish to use a different broker you will need to arrange to have the holding transferred.
How do I update my address details?
For Issuer Sponsored shares, you will be able to update your new address details online with Computershare. You may contact Computershare Investor Services on Computershare Investor Services on 1300 850 505 (from Australia) or +61 3 9415 4000 (from overseas). Follow the link to access a change of address form for shareholders and other downloadable forms.
For Broker Sponsored shares, you will need to notify your broker in writing of your change of address.
What is a HIN?
The Holder Identification Number (HIN) identifies your registration on the CHESS Subregister. One HIN can register an investor’s shareholdings in multiple companies. For example, if you hold shares in Companies X, Y and Z, these shareholdings can be consolidated in one registration under a single HIN.
What is a SRN?
The Shareholder Registration Number (SRN) identifies your registration on an Issuer Sponsored Subregister. An SRN registers an investor’s shareholding in a single listed company. If you hold shares in more than one company and choose to be Issuer Sponsored, you will have a different SRN for each shareholding.
What is a duplicate account?
If you have two or more SRN and/or HIN then you may have unnecessary duplication of accounts. HINs are issued to holders who are sponsored through CHESS. The duplication of accounts impacts all shareholders by increasing maintenance and administrative costs. It may also mean that you receive duplicate quarterly and annual reports.
When our Share Registry locates duplicate accounts, they will contact the shareholder to determine if the accounts can be amalgamated. Unfortunately, some of the duplication goes across register modes. Shareholders with duplicate accounts should contact the Share Registry who will take you through the steps to amalgamate the accounts.
Does Benitec Biopharma have an American Depositary Receipts (ADR) program?
Benitec’s ADR shares have now converted to American Depositary Shares (ADS) which are traded on NASDAQ under the ticker BNTC.
I have a question which hasn’t been answered here. What should I do?
Investors are invited to send enquiries to Benitec by filling out this form. It should be noted that the company will at all times comply with its continuous disclosure obligations, in accordance with the ASX listing rules. All material communications will be issued via ASX and will also be made available through the Company’s website. Benitec is unable to provide information or comments to individual shareholders on matters that have not been disclosed to the market.